Cardinal Health Inc vs JPMorgan Ultra Short Income ETF — how do they compare? Cardinal Health Inc trades at $240.57 (market cap $55.88B), while JPMorgan Ultra Short Income ETF trades at $50.45. The key difference: Cardinal Health Inc pays a 0.86% dividend while JPMorgan Ultra Short Income ETF pays none, and Cardinal Health Inc is trading nearer its 52-week high, JPMorgan Ultra Short Income ETF nearer its low. Which is the better fit depends on your goals.
| CAH | JPST | |
|---|---|---|
Market Cap | $55.88B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $240.26 | $50.78 |
52-Week Low | $146.04 | $50.40 |
Enterprise Value | $59.91B | — |
Dividend Yield | 0.86% | — |
Trailing returns across standard periods
Latest headlines on both assets
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →JPST is an actively managed ETF that invests in short-term, investment-grade fixed income securities. It aims to provide current income and capital preservation while maintaining high liquidity.
Read more on JPST →